Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Repligen is a leading US-based company providing innovative bioprocessing technologies for biopharmaceutical development and manufacturing. Specializing in filtration, chromatography, and cell culture media, Repligen delivers essential solutions and single-use systems for global life sciences. The company supports increased efficiency in biopharmaceutical production.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Repligen is scheduled to report its next quarterly earnings on 11/03/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Repligen last reported quarterly earnings on 7/28/2026 (Q2 2026). Earnings per share (EPS) came in at 0.54 USD.
Across its last 3 earnings reports, Repligen stock moved by ±4.2% on average the following day. The largest reaction was +6.3% on 05/05/2026; 1 of 3 reactions were positive.
Repligen has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.